Warning letterFDA · May 18, 2021
Umbrella MARCS-CMS 612037, May 18, 2021
Named company: Umbrella
As described below, these products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) [21 U.S.C. §§ 355(a) and 301(d)] and…
Lot information: not specified in this record.